Error: Could not add to watchlist. X
+ Watchlist

Generali Fond farmacie a biotechnologie

FFBCPIN:CP
1.8229
CZK
As of 10/12/2017
Fund Type
Open-End Fund
52Wk Range
1.5448 - 1.8236
Before it's here, it's on the Bloomberg Terminal.
Learn More
52Wk Range
1.5448 - 1.8236
1 Yr Return
11.98%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Multi
NAV (on 10/12/2017)
1.8229
Total Assets (b CZK) (on 10/12/2017)
1.299
Inception Date
01/09/2002
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
MARTIN PECKA
Front Load Fee
-
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
-
Expense Ratio
-

Top Fund Holdings

Name Position Value % of Fund
26.36 k 56.22 m 4.45
28.52 k 52.48 m 4.15
13.21 k 51.60 m 4.08
65.03 k 48.48 m 3.83
16.24 k 45.69 m 3.61
25.86 k 42.80 m 3.39
13.06 k 39.87 m 3.15
12.85 k 37.40 m 2.96
32.89 k 36.82 m 2.91
9.54 k 33.66 m 2.66
Profile
Generali Fond farmacie a biotechnologie is an open-end fund incorporated in Czech Republic. The Funds objective is long-term capital growth. The fund invests primarily in equity securities issued by larger pharmaceutical and biotechnology companies located in the United States and Europe.
Address
Generali Investments CEE
Na Pankráci 1720/123, P.O.Box 39
140 21, Prague 4
Czech Republic
Phone
Tel.: +420 281 044 198